4-Methyl-2,5-methoxyphenylcyclopropylamine
From Wikipedia, the free encyclopedia
![]() |
|
![]() |
|
Names | |
---|---|
IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine
|
|
Identifiers | |
3D model (Jmol)
|
|
ChemSpider | |
PubChem CID
|
|
|
|
|
|
Properties | |
C12H17NO2 | |
Molar mass | 207.27 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
DMCPA, or 4-methyl-2,5-methoxyphenylcyclopropylamine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–20 mg, and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.
Pharmacology[edit]
Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.
See also[edit]
External links[edit]
![]() |
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |